Adenoviruses containing lethal in-frame insertion mutant alleles of the preterminal protein (pTP) gene were constructed with cell lines that express pTP. Thirty in-frame insertion mutant alleles, including 26 alleles previously characterized as lethal and 4 newly constructed mutant alleles, were introduced into the viral chromosome in place of the wild-type pTP gene. The viruses were tested for ability to form plaques at 37°C in HeLa-pTP cells and at 32°C and 39.5°C in HeLa cells. Two of the newly constructed viruses exhibited temperature sensitivity for plaque formation, one virus did not form plaques in the absence of complementation, seven additional mutants exhibited a greater than 10-fold reduction in plaque formation in the absence of complementation, and another eight mutants exhibited stronger phenotypes than did previously characterized in-frame insertion mutants in the plaque assay. These mutant viruses offer promise for analysis of pTP functions.
Adenovirus replication is absolutely dependent on virally encoded DNA binding protein, preterminal protein (pTP), and DNA polymerase (Pol). pTP serves as a primer to which the first base, a dCMP residue, is covalently bound (for a review of adenovirus replication, see references 12 and 29) . pTP is proteolytically matured following encapsulation of the DNA to yield terminal protein (TP), the form of the protein found in infectious virions (5) . The function of the proteolytic processing is not known.
pTP and TP act to bind the adenovirus chromosome to the nuclear matrix (3, 7, 25) and to facilitate efficient transcription of viral early-region genes (23, 25) . Binding of pTP and TP to the nuclear matrix occurs through interaction with the CAD enzyme (2) in a manner that is regulated by tyrosine phosphorylation (3) .
Genetic studies of the roles of pTP in the infectious cycle have been limited by difficulties in isolating pTP mutant viruses with strong phenotypes. In two studies, in-frame insertion mutant alleles of pTP were generated in vitro, after which attempts to introduce the mutant alleles into the viral chromosome were made (9, 19, 20) . Of the 56 alleles constructed, 26 were successfully introduced into the viral chromosome, of which two caused moderately strong phenotypes, three caused weaker phenotypes, and the remainder caused no phenotype (9, 19, 20) . The alleles that could not be inserted into the viral chromosome were termed lethal. It was among the lethal alleles that we expected to find the most interesting and informative phenotypes.
pTP is involved in the rate-limiting step at initiation of adenovirus replication. While the use of virions makes adenovirus DNA extremely infectious, the use of purified DNA introduced into cells by transfection greatly reduces the infectivity of adenovirus DNA. The infectivity of the DNA can be increased by using adenovirus DNA-TP complex (6) , but the resulting infectivity is still many orders of magnitude lower than that of DNA within virions. Since standard methods for introduction of mutated pTP alleles into the viral chromosome require the transfection of either naked adenovirus DNA or DNA-TP complex, the reduced infectivity of DNA and DNA-TP complex offers a likely explanation for the difficulty in generating pTP mutant viruses that exhibit strong phenotypes: even a modest effect on the ability of pTP to act in initiating adenovirus replication may make the mutation appear to be lethal by preventing the overlap recombination required to form virus. However, we expected that cell lines that express pTP (1, 13, 15, 21) would permit construction of the pTP mutant viruses, that once the pTP mutation was incorporated into the viral chromosome in place of the wild-type allele and virions were generated, the vastly increased infectivity of virions would overcome the limitations that blocked construction of the pTP mutant viruses by standard means, and that, therefore, the majority of the mutant viruses would grow in the absence of complementation.
Construction of viruses containing lethal pTP in-frame insertion mutant alleles. A system for construction of viruses containing pTP mutant alleles that permitted screening or selection for the desired viruses was developed (Fig. 1) . This procedure was found to efficiently select for the desired viruses.
pTP in-frame insertion mutant viruses plaque purified with HeLa-pTP cells were grown in 293-pTP cells. Viral DNA was prepared by the method of Hardy et al. (11) and analyzed for the presence of the inserted restriction site within the pTP gene, the presence of the BstBI site within the E1A gene, and the absence of the KpnI site at bp 2052 within the E1B gene (the mutations in the E1 genes, which do not affect function of the proteins, were introduced to facilitate cloning [22] ). In addition, the sizes of the fragments generated by digestion with the restriction enzyme cleaving the introduced sequence within the pTP gene were compared. This analysis demonstrated the successful construction of the library of lethal pTP in-frame insertion mutant viruses (Table 1) .
Initial characterization of the pTP in-frame insertion mutants. Stocks of the pTP in-frame insertion mutant viruses grown in 293-pTP cells were plaque titered with, as controls, the phenotypically wild-type Ad5dl309, the temperature-sensitive (ts) pTP mutant virus Ad5sub100r, and Ad5dl308pTP155 (equivalent to Ad5in425 [9] ) in HeLa-pTP cells at 37°C and in HeLa cells at 32°C and 39.5°C. The input virus had either the mutant form of TP encoded by the virus or the wild-type TP encoded by 293-pTP cells covalently attached to the viral DNA. In cases where wild-type TP was associated with the DNA, it is possible that an advantage for virus replication was provided. However, this advantage would have been apparent only for the input viral genome and thus would have provided a linear, rather than exponential, advantage to virus growth. Thus, plaque formation would have been dependent on the ability of the mutated pTP to promote virus formation.
The results (Table 2 ) demonstrated that virus yields from 293-pTP cells varied over nearly 3 orders of magnitude among the newly constructed pTP in-frame mutant viruses in spite of similar progression of cytopathic effect. Since virus growth was in the presence of complementing pTP supplied by the cells and was not optimized for the individual viruses, the differences in yield, while suggestive of phenotypic differences due to the mutations introduced into the pTP gene, cannot be considered as a primary indicator of phenotype for the purposes of classification until virus growth is examined in detail in noncomplementing cells. Comparison of relative plaquing efficiencies in HeLa and HeLa-pTP cells normalizes for differences in yield and so offers strong evidence of phenotypic differences. Since certain mutant adenoviruses, including viruses deleted in the E1A and E1B genes, are capable of growing more efficiently after infection of noncomplementing cells at high multiplicity (26) , plaque formation represents a fairly strict definition of viral replication.
Both Ad5sub100r and Ad5in425 exhibited fairly strong phenotypes in 293 cells (9, 18, 21) in contrast to the weaker phenotypes apparent in plaque assays in HeLa cells ( Table 2) , suggesting that HeLa cells may partially complement growth of adenoviruses mutated in the pTP gene relative to 293 cells. Thus, reliance on significant reductions in plaque-forming efficiency in HeLa cells for phenotypic comparison sets a fairly rigorous standard for the definition of mutant behavior.
All but one of the newly constructed mutant viruses, Ad5dl308pTP120, were able to grow to form plaques in the absence of complementation. The mutation in Ad5dl308 pTP120 may truly be lethal because of nonfunctional pTP. Alternatively, it is possible that the pTP allele may not direct expression of pTP.
In the absence of complementation, Ad5dl308pTP111, Ad5dl308pTP243, Ad5dl308pTP252, Ad5dl308pTP590, and Ad5dl308pTP609 formed plaques 10-to 100-fold less efficiently and Ad5dl308pTP108-1, Ad5dl308pTP108-2, Ad5dl308pTP125, and Ad5dl308pTP508 formed plaques at least 100-fold less efficiently than they did in the presence of complementation. Ad5dl308pTP108-2 and Ad5dl308pTPR508 also exhibited ts plaque formation in the absence of complementation. The phenotypes of all of these mutants, particularly the ts mutants, appeared to be much stronger than those of any of the previously constructed pTP mutants, excluding pTP deletion mutants.
The remaining viruses included 8 that exhibited stronger phenotypes than either Ad5sub100r or Ad5dl308pTP155 and 12 that exhibited little or no phenotype in the plaque assays. Since both Ad5sub100r (9, 21, 23, 25) and Ad5in425 (9, 18) exhibit interesting and informative phenotypes, it is likely that at least some of the less-defective pTP mutant viruses will exhibit stronger phenotypes in other assays of virus growth. Such assays will include one-step growth curves, determination of relative affinities of the viral chromosomes for the nuclear matrix, and analysis of the synthesis and fate of pTP in cells infected with the various pTP mutant viruses. The fact that the great majority of the pTP mutant viruses grow, at least to a low level, in the absence of complementation will facilitate studies of pTP function. Any pTP mutant that can be generated is of potential value, but the viruses that can be grown in the absence of complementation have expanded potential, since growth in the absence of complementation ensures that the mutant forms of pTP and TP are associated with all viruses in a stock. This will permit the effects of most of the mutations to be examined throughout the infectious cycle.
Viruses that did not display a strong phenotype were retested for the presence of the restriction site introduced within the pTP gene. Aliquots of the stocks used in plaque titration were grown in 293-pTP 2C1 cells and DNA isolated (11) . All of the viruses maintained the restriction enzyme site introduced in the mutated pTP allele (data not shown), demonstrating that the lack of a strong phenotype in plaque formation in HeLa cells was characteristic of the mutation and did not result from recombination within the pTP-expressing cells or contamination with the wild-type virus.
Examination of the pTP mutant map (Fig. 2) demonstrates regions of clustering of strong phenotypes near amino acid 120, suggesting that this region is particularly important for pTP function. Stronger conclusions will require further mutagenesis of pTP.
Fredman et al. (8) examined the ability of certain of the pTP proteins encoded by mutant alleles constructed by Freimuth and Ginsberg (9) to direct replication in vitro. The results that pertain to viruses examined in this study are indicated in Table  2 . Reasonable agreement between the in vitro results and results of the plaque formation assay were observed for Ad5dl308pTP125 and Ad5dl308pTP378 (in both cases in comparison with paired mutant alleles generated by Freimuth and Ginsberg [9] ), Ad5dl308pTP403, and Ad5dl308pTPF155. Ad5sub100r pTP directed poor replication in vitro (8) but had only modest effects on plaque formation in HeLa cells. The in f Amino acids encoded by the mutated allele. The inserted amino acids are indicated between hyphens, and the amino acids mutated by the insertion are underlined. g Plasmid source of the DNA. Plasmids with the prefix R were constructed by Roovers et al. (19, 20) , plasmids with the prefix F were constructed by Freimuth and Ginsberg (9) , and plasmids with the prefix H were newly constructed for this study.
h The first codon in the inserted sequence recreated the codon immediately 3Ј to the insertion site. i One of the three most C-terminal mutations, which lie within the overlapping sequence that encodes the N-terminal region of DNA pol.
vitro replication data are thus in better agreement with the results of plaque formation by the virus in 293 cells (9, 21) than with the results of plaque formation by the virus in HeLa cells. The F233 mutation has a strong effect on the progression of Ad5in425 through the infectious cycle (9, 18) but relatively little effect on plaquing efficiency, supporting the suggestion that the mutation affects a pTP function separate from its role in replication (8) . The pTP alleles encoded by F391, F439, and F348 did not direct synthesis of pTP in vitro (8) . The ability of the viruses generated by using these alleles, Ad5dl308pTP88-2, Ad5dl308pTP252-2, and Ad5dl308pTP534, respectively, to form plaques in HeLa cells indicates that pTP synthesis was directed in vivo. However, pTP encoded by all of these alleles, and by their paired counterparts with insertions at the same sites generated by Roovers et al. (19, 20) , may act as dominant negatives, as yields of these viruses grown in 293-pTP cells were reduced 40-to 90-fold relative to the highest yields of a Stocks of the pTP mutants (all of which are in the Ad5dl308 background, but which are named here simply by the pTP mutation site) and various control viruses grown in 293-pTP 2C1 cells (except for the Ad5dl309 stock, which was grown in 293 cells [10] ) were plaque titered with HeLa-pTP cells at 37°C and HeLa cells at both 32°C and 39.5°C.
b The position of the insertion mutation is as indicated in Table 1 . c Ratios of plaque titers in HeLa-pTP cells to those in HeLa cells are presented normalized to plaque titers observed for Ad5dl309 for both temperatures examined for HeLa cells.
d The phenotype of the virus determined from relative plaquing efficiency. rd, replication defective (defined here as a 10-to 99-fold reduction in plaquing efficiency in HeLa cells relative to that in HeLa-pTP cells; rd*, indicates severely replication defective (defined here as at least a 100-fold a reduction in plaquing efficiency in HeLa cells relative to that in HeLa-pTP cells; ts, temperature-sensitive behavior (defined here as a greater than 10-fold increase in plaquing efficiency at 32°C relative to that at 39.5°C in HeLa cells).
e The phenotype in in vitro replication assays determined with data derived from Fredman et al. (8) . No pTP, pTP synthesis was not directed by the pTP; ϪϪ, the protein directed replication activity less than 5% of that of the wild-type pTP in both initiation and elongation assays; Ϫ, the protein directed replication activity less than 30% and greater than 5% of that of the wild-type allele; ϩϩ, the protein directed replication activity greater than 50% of that of the wild-type pTP. In cases where results were obtained using an allele mutagenized at the same site as a mutant virus created in this study, the results are presented in parentheses.
f Control virus.
pTP in-frame insertion mutants (Table 2 ) and pTP deletion mutant viruses (data not shown). F346 and F394 both directed little or no replication in vitro (8) . The F346 mutation in Ad5dl308pTP234-2 led to only a modest phenotype in the plaque formation assays. The F394 mutation in Ad5dl308pTP478 led to a stronger phenotype, although possibly not as strong as predicted from the in vitro replication results. The increased effect of the mutations in vitro may reflect the stringency of the assay, since replication in vitro is inefficient relative to that in vivo. Alternatively, the formation of complexes with DNA Pol (14, 28) may help to stabilize the mutant pTPs in vivo. (27) , are indicated as ticks on the pTP coding sequence, with numbering shown below. The positions of viable in-frame pTP mutations introduced into the virus in earlier studies (9, 19, 20) are indicated by vertical lines below the pTP coding sequence, with the positions of mutations leading to replication-defectiveness (9) indicated by elongated lines. The positions of mutations introduced into the virus in this study are indicated above the pTP coding sequence, with the positions of mutations leading to strongly defective behavior (at least a 10-fold reduction in plaquing efficiency in HeLa cells relative to that in HeLa-pTP cells) indicated by elongated lines. The overlapping coding sequence for DNA Pol is indicated by the dashed line with arrow.
